Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD-CARhE
NCT04339270Phase 4Recruiting
- Sponsor
- CHU Montpellier
- Start
- Feb 2023
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in chronic obstructive pulmonary disease (COPD), sponsored by CHU Montpellier. Started Feb 2023; status: recruiting.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04339270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04339270.